Document ID: chunk:federal_register_of_legislation:F2025C00124:reg:38
Version: federal_register_of_legislation:F2025C00124
Segment Type: reg
Provision Reference: reg 38
Character Range: 59221–59963

38  HSD hospital authorities
  Despite the repeal of the National Health (Highly specialised drugs program) Special Arrangement 2010 (PB 116 of 2010):
 (a) an approval that was in force under subsection 52(2) of that instrument immediately before 1 April 2021; and
 (b) an approval that was continued in force under section 53 of that instrument as if it were an approval under subsection 52(2) of that instrument, and was in force immediately before 1 April 2021;
continues in force as if it were an approval under section 94 of the Act, as modified by section 10 of this instrument.

Division 2—Provisions relating to the National Health Legislation Amendment (Opioid Dependence Treatment and Maximum Dispensed Quantities) Instrument 2023